CC BY 4.0 · J Brachial Plex Peripher Nerve Inj 2022; 17(01): e12-e21
DOI: 10.1055/s-0042-1748535
Original Contribution

Follistatin Protein Enhances Satellite Cell Counts in Reinnervated Muscle

Mark A. Feger
1   Department of Orthopedic Surgery, Washington University School of Medicine, St. Louis, Missouri, United States
,
Jonathan Isaacs
2   Division of Hand Surgery, Department of Orthopaedic Surgery, Virginia Commonwealth University Medical Center, Richmond, Virginia, United States
,
Satya Mallu
2   Division of Hand Surgery, Department of Orthopaedic Surgery, Virginia Commonwealth University Medical Center, Richmond, Virginia, United States
,
Dorne Yager
3   Divison of Plastic Surgery, Department of General Surgery, Virginia Commonwealth University Medical Center, Richmond, Virginia, United States
,
Mary Shall
4   Department of Physical Therapy, Virginia Commonwealth University Medical Center, Richmond, Virginia, United States
,
Gaurangkumar Patel
2   Division of Hand Surgery, Department of Orthopaedic Surgery, Virginia Commonwealth University Medical Center, Richmond, Virginia, United States
,
Omar Protzuk
2   Division of Hand Surgery, Department of Orthopaedic Surgery, Virginia Commonwealth University Medical Center, Richmond, Virginia, United States
,
Akhil S. Bokkisam
2   Division of Hand Surgery, Department of Orthopaedic Surgery, Virginia Commonwealth University Medical Center, Richmond, Virginia, United States
› Author Affiliations
Funding The study was funded through the Department of Defense, U.S. Army Medical Research and Materiel Command, Congressionally Directed Medical Research Programs, Peer Reviewed Orthopaedic Research Program (Award Number: W81XWH-15-1-0229).. Microscopy was performed at the VCU Microscopy Facility, supported, in part, by funding from NIH-NCI Cancer Center Support Grant P30 CA016059.

Abstract

Background Muscle recovery following peripheral nerve repair is sup-optimal. Follistatin (FST), a potent muscle stimulant, enhances muscle size and satellite cell counts following reinnervation when administered as recombinant FST DNA via viral vectors. Local administration of recombinant FST protein, if effective, would be more clinically translatable but has yet to be investigated following muscle reinnervation.

Objective The aim of this study is to assess the effect of direct delivery of recombinant FST protein on muscle recovery following muscle reinnervation.

Materials and Methods In total, 72 Sprague-Dawley rats underwent temporary (3 or 6 months) denervation or sham denervation. After reinnervation, rats received FST protein (isoform FS-288) or sham treatment via a subcutaneous osmotic pump delivery system. Outcome measures included muscle force, muscle histomorphology, and FST protein quantification.

Results Follistatin treatment resulted in smaller muscles after 3 months denervation (p = 0.019) and reduced force after 3 months sham denervation (p < 0.001). Conversely, after 6 months of denervation, FST treatment trended toward increased force output (p = 0.066). Follistatin increased satellite cell counts after denervation (p < 0.001) but reduced satellite cell counts after sham denervation (p = 0.037).

Conclusion Follistatin had mixed effects on muscle weight and force. Direct FST protein delivery enhanced satellite cell counts following reinnervation. The positive effect on the satellite cell population is intriguing and warrants further investigation.



Publication History

Received: 27 July 2020

Accepted: 18 February 2021

Article published online:
21 June 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Sakellarides H. A follow-up study of 172 peripheral nerve injuries in the upper extremity in civilians. J Bone Joint Surg Am 1962; 44-A: 140-148
  • 2 Jongen SJ, Van Twisk R. Results of primary repair of ulnar and median nerve injuries at the wrist: an evaluation of sensibility and motor recovery. Neth J Surg 1988; 40 (03) 86-89
  • 3 Roganovic Z. Missile-caused median nerve injuries: results of 81 repairs. Surg Neurol 2005; 63 (05) 410-418 , discussion 418–419
  • 4 Secer HI, Daneyemez M, Gonul E, Izci Y. Surgical repair of ulnar nerve lesions caused by gunshot and shrapnel: results in 407 lesions. J Neurosurg 2007; 107 (04) 776-783
  • 5 Ruijs AC, Jaquet JB, Kalmijn S, Giele H, Hovius SE. Median and ulnar nerve injuries: a meta-analysis of predictors of motor and sensory recovery after modern microsurgical nerve repair. Plast Reconstr Surg 2005; 116 (02) 484-494 , discussion 495–496
  • 6 Fu SY, Gordon T. Contributing factors to poor functional recovery after delayed nerve repair: prolonged denervation. J Neurosci 1995; 15 (5 Pt 2): 3886-3895
  • 7 Lien SC, Cederna PS, Kuzon Jr WM. Optimizing skeletal muscle reinnervation with nerve transfer. Hand Clin 2008; 24 (04) 445-454 , vii vii.
  • 8 Cederna PS, Youssef MK, Asato H, Urbanchek MG, Kuzon Jr WM. Skeletal muscle reinnervation by reduced axonal numbers results in whole muscle force deficits. Plast Reconstr Surg 2000; 105 (06) 2003-2009 , discussion 2010–2011
  • 9 Anzil AP, Wernig A. Muscle fibre loss and reinnervation after long-term denervation. J Neurocytol 1989; 18 (06) 833-845
  • 10 Ontell M. Muscle satellite cells: a validated technique for light microscopic identification and a quantitative study of changes in their population following denervation. Anat Rec 1974; 178 (02) 211-227
  • 11 Schultz E. Changes in the satellite cells of growing muscle following denervation. Anat Rec 1978; 190 (02) 299-311
  • 12 Moss FP, Leblond CP. Satellite cells as the source of nuclei in muscles of growing rats. Anat Rec 1971; 170 (04) 421-435
  • 13 Hill M, Wernig A, Goldspink G. Muscle satellite (stem) cell activation during local tissue injury and repair. J Anat 2003; 203 (01) 89-99
  • 14 Kobayashi J, Mackinnon SE, Watanabe O. et al. The effect of duration of muscle denervation on functional recovery in the rat model. Muscle Nerve 1997; 20 (07) 858-866
  • 15 Aydin MA, Mackinnon SE, Gu XM, Kobayashi J, Kuzon Jr WM. Force deficits in skeletal muscle after delayed reinnervation. Plast Reconstr Surg 2004; 113 (06) 1712-1718
  • 16 Isaacs J, Feher J, Shall M. et al. Effects of nandrolone on recovery after neurotization of chronically denervated muscle in a rat model. J Neurosurg 2013; 119 (04) 914-923
  • 17 McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387 (6628): 83-90
  • 18 Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kambadur R. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 2002; 277 (51) 49831-49840
  • 19 McPherron AC, Lee SJ. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A 1997; 94 (23) 12457-12461
  • 20 Kambadur R, Sharma M, Smith TP, Bass JJ. Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res 1997; 7 (09) 910-916
  • 21 Grobet L, Martin LJ, Poncelet D. et al. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet 1997; 17 (01) 71-74
  • 22 Bogdanovich S, Krag TO, Barton ER. et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 2002; 420 (6914): 418-421
  • 23 Lee SJ. Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways. PLoS One 2007; 2 (08) e789
  • 24 Zhu J, Li Y, Lu A. et al. Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis. Am J Pathol 2011; 179 (02) 915-930
  • 25 Isaacs J, Feger MA, Mallu S. et al. Viral vector delivery of follistatin enhances recovery of reinnervated muscle. Muscle Nerve 2019; 60 (04) 474-483 Epub20190801.
  • 26 Isaacs J, Loveland K, Mallu S, Adams S, Wodicka R. The use of anabolic steroids as a strategy in reversing denervation atrophy after delayed nerve repair. Hand (N Y) 2011; 6 (02) 142-148
  • 27 Shin RH, Vathana T, Giessler GA, Friedrich PF, Bishop AT, Shin AY. Isometric tetanic force measurement method of the tibialis anterior in the rat. Microsurgery 2008; 28 (06) 452-457
  • 28 Rose Jr FF, Mattis VB, Rindt H, Lorson CL. Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy. Hum Mol Genet 2009; 18 (06) 997-1005
  • 29 Rodino-Klapac LR, Haidet AM, Kota J, Handy C, Kaspar BK, Mendell JR. Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle Nerve 2009; 39 (03) 283-296
  • 30 Yaden BC, Croy JE, Wang Y. et al. Follistatin: a novel therapeutic for the improvement of muscle regeneration. J Pharmacol Exp Ther 2014; 349 (02) 355-371
  • 31 Gangopadhyay SS. Systemic administration of follistatin288 increases muscle mass and reduces fat accumulation in mice. Sci Rep 2013; 3: 2441
  • 32 Viguie CA, Lu DX, Huang SK, Rengen H, Carlson BM. Quantitative study of the effects of long-term denervation on the extensor digitorum longus muscle of the rat. Anat Rec 1997; 248 (03) 346-354
  • 33 Wu RH, Wang P, Yang L, Li Y, Liu Y, Liu M. A potential indicator of denervated muscle atrophy: the ratio of myostatin to follistatin in peripheral blood. Genet Mol Res 2011; 10 (04) 3914-3923
  • 34 Amthor H, Nicholas G, McKinnell I. et al. Follistatin complexes myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev Biol 2004; 270 (01) 19-30
  • 35 Zimmers TA, Davies MV, Koniaris LG. et al. Induction of cachexia in mice by systemically administered myostatin. Science 2002; 296 (5572): 1486-1488
  • 36 Armand AS, Della Gaspera B, Launay T, Charbonnier F, Gallien CL, Chanoine C. Expression and neural control of follistatin versus myostatin genes during regeneration of mouse soleus. Dev Dyn 2003; 227 (02) 256-265